Dr Hester Lieng

BSc (Med), MBBS, FRANZCR
Radiation Oncologist
Become a Patient

Biography

Dr Hester Lieng is an experienced radiation oncologist at Icon Cancer Centre Gosford. In 2005 she completed her Bachelor of Science (Medicine) and Bachelor of Medicine, Bachelor of Surgery (MBBS) with Honours at the University of New South Wales. Dr Lieng subsequently undertook specialist radiation oncology training at Westmead, Nepean and Royal North Shore Hospitals. She also completed a genitourinary clinical and research fellowship at Princess Margaret Cancer Centre in Toronto, Canada. In 2016 Dr Lieng became a fellow of the Royal Australian and New Zealand College of Radiologists (FRANZCR).

Dr Lieng is actively involved in clinical research and medical education, with a particular interest in breast, gynaecological and genitourinary cancers. She is the principal investigator for the EXPERT (examining personalised radiation therapy for low-risk early breast cancer) clinical trial at Gosford Hospital. Dr Lieng is an invited speaker at national and international conferences and is also involved in medical student and registrar education through her conjoint senior lecturer and radiation oncology coordinator positions at the University of Newcastle and NSW Radiation Oncology Training Network.

Affiliations & Memberships

  • American Society for Radiation Oncology (ASTRO)
  • Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
  • Australia New Zealand Gynaecological Oncology Group (ANZGOG)
  • European Society for Radiotherapy & Oncology (ESTRO)
  • Royal Australian and New Zealand College of Radiologists (RANZCR)
  • Trans Tasman Radiation Oncology Group (TROG)

Special Interests

Dr Hester Lieng only accepts referrals for the following cancer types:
  • Breast cancer
  • Genitourinary cancer
  • Gynaecological cancer

Icon Locations

Gosford View centre

Visiting Locations

  • Central Coast Cancer Centre

Publications

  • Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group. H. Lieng, A. Kneebone, A.J. Hayden, D.R.H. Christie, B.J. Davis, T.N. Eade, L. Emmett, T. Holt, G. Hruby, D. Pryor, M. Sidhom, M. Skala, J. Yaxley & T.P. Shakespeare. Radiotherapy and Oncology, 2019; 140: 68-75.

  • Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group. Lieng, A.J. Hayden, D.R.H. Christie, B.J. Davis, T.N. Eade, L. Emmett, T. Holt, G. Hruby, D. Pryor, T.P. Shakespeare, M. Sidhom, M. Skala, K. Wiltshire, J. Yaxley &, A. Kneebone. Radiotherapy and Oncology, 2018; 129(2): 377-386.

  • Testicular seminoma: Scattered radiation dose to the contralateral testis in the modern era. H. Lieng, P. Chung, T. Lam, P. Warde & T. Craig. Practical Radiation Oncology, 2018; 8(2): e57-e62.

  • Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach. H. Lieng, P. Warde, P. Bedard, R.J. Hamilton, A.R. Hansen, M.A.S. Jewett, M. O’Malley, J. Sweet & P. Chung. Canadian Urological Association Journal, 2018; 12(2): 59-66.

  • Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer. H. Lieng, M. Pintilie, A. Bayley, A. Berlin, R. Bristow, P. Chung, M. Gospodarowicz, R. Huang, C. Ménard, P. Warde & C. Catton. Radiotherapy and Oncology, 2017; 122(1): 93-98.